載入...
BCLC-B hepatocellular carcinoma treatment or when should the systemic therapy be started
Choice of the optimal therapy for BCLC-B hepatocellular carcinoma (HCC) is a significant clinical problem. Transarterial chemoembolisation (TACE) is considered to be the method of choice as this approach is reported to produce a direct effect and to have a significant survival rate. However, TACE is...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Russo |
| 出版: |
Remedium Group LLC
2018-07-01
|
| 叢編: | Медицинский совет |
| 主題: | |
| 在線閱讀: | https://www.med-sovet.pro/jour/article/view/2529 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|